Ligand Pharmaceuticals
LGND
#4056
Rank
S$3.04 B
Marketcap
$161.20
Share price
-1.10%
Change (1 day)
65.06%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.08

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.10. In 2022 the company made an earnings per share (EPS) of -$2.65 a decrease over its 2021 EPS that were of $4.62.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.08-178.54%
2022-$2.65-157.23%
2021$4.62-2571.43%
2020-$0.19-100.46%
2019$40.89353.48%
2018$9.021025%
2017$0.80-700%
2016-$0.13-100.87%
2015$15.441859.32%
2014$0.795.36%
2013$0.758.0704505322479E+18%
2012$0.0000000000-100%
2011$0.65-194.23%
2010-$0.69548.38%
2009-$0.11-98.7%
2008-$8.26-136.52%
2007$22.60-787.8%
2006-$3.29-14.58%
2005-$3.85-21.31%
2004-$4.89-55.15%
2003-$10.9081.33%
2002-$6.012.74%
2001-$5.85-45.93%
2000-$10.82-14.56%
1999-$12.66-45.52%
1998-$23.24-3.97%
1997-$24.21132.31%
1996-$10.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.90 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.68 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.43 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.48 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.25 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.30 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.84 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.82 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA